RHÖN-KLINIKUM AG / Key word(s): Half Year Results09.08.2012 / 06:59
 Patient number climb by 9.5%, revenues by 7.1%  First-time consolidation of HSK Delay in restructuring of UKGM  Collective wage deals at higher end of expected range  Extraordinary effects as a result of takeover offer in second quarter Forecast for the year adjusted by EUR 25 million to EUR 30 million Bad Neustadt a. d. Saale, 9 August 2012Patient numbers and revenues within the Group of RHÖN-KLINIKUM AG onceagain witnessed significant growth in the first half of 2012. In the firstsix months, 1.26 million patients were treated, 9.5% more than over thesame period of the previous year. Revenues climbed by 7.1% to EUR 1.39billion. In addition to the pleasing organic growth in revenues, thefirst-time consolidation of Dr. Horst Schmidt Kliniken (HSK) in Wiesbadentook place as at 1 May 2012.For the reporting period, the result declined. In addition to the lossesacquired from HSK, this is explained chiefly by the following developments: Delays in the restructuring of the University Hospitals Gießen andMarburg (UKGM) are expected to burden the operating result by roughly EUR20 million for full-year 2012. The high collective wage deals recently negotiated and the decline inprices that has now persisted for two years are having a double adverseimpact on the earnings situation of our hospitals. The takeover offer by Fresenius significantly impaired the result due toone-off consulting fees and the noticeable insecurity created within theorganisation.Specifically, operating EBITDA worsened by 10.2% to EUR 145.2 million inthe first six months of the year. Given higher amortisation on new hospitalbuildings, EBIT fell by 24.9% to EUR 76.8 million. Burdened by higherinterest and a one-off tax effect from the previous period, netconsolidated profit declined by 40.5% to EUR 50.1 million. After deductingminority interests in profit of EUR 1.2 million from net consolidatedprofit of the first six months, earnings per ordinary share (EpS) stood atEUR 0.35 (previous year: EUR 0.59).'Although the first half of the year also reveals negative points, theseare outweighed by the positive ones', said Wolfgang Pföhler, chairman ofthe Board of Management of RHÖN-KLINIKUM AG. 'The rising patient numbersare proof of the high quality level of our facilities and the outstandingperformance of our more than 40,000 employees. We see our revenue figures,which were additionally positively impacted by the consolidation of HSK, asbeing on a good path. The earnings performance seen over the past sixmonths is certainly not satisfactory, but this was also due to negativeone-off effects.'Outlook With regard to full-year 2012, Pföhler emphasised: 'Our expectations forthe second half are cautiously optimistic. Wage increases can be offset inpart by the most recent decisions of the German legislator. It is true thatthe measures are not remotely sufficient, but they will bring about apositive effect. At UKGM initial steps to improve efficiency have alreadybeen taken by the management. These will also help improve the earningssituation in the medium term. As before, the consequences of the failedtakeover offer at the end of June are not foreseeable. The possibility offurther burdens arising here cannot be ruled out.'RHÖN-KLINIKUM AG has adjusted its forecast for financial year 2012 asfollows:For financial year 2012, including HSK consolidated for the first time atthe end of April, RHÖN-KLINIKUM AG expects revenues of EUR 2.85 billion,which may fluctuate within a range of plus or minus 2.5 per cent. Thisrevenue target is accompanied by a forecast for EBITDA of EUR 315 millionand for net consolidated profit of EUR 117 million, in each case subject toa variation of +/- 5 per cent.We will continue to show our core competences to lie in efficiency andquality, not least with the integration and restructuring of our latestacquisition, Dr. Horst Schmidt Kliniken', Pföhler stated in conclusion.Contacts:Max MuellerDirector Corporate CommunicationsFriedrichstraße 82D-10117 BerlinPhone: +49 30 20603-700Fax: +49 30 20603-701Mobile: +49 171 5491487Email: max.mueller@rhoen-klinikum-ag.comDr. Kai G. KlingerHead of Investor RelationsSchlossplatz 1D-97616 Bad Neustadt a. d. SaalePhone: +49 9771 65-1318Fax: +49 9771 99-1736Mobile: +49 151 12582707Email: kai.klinger@rhoen-klinikum-ag.com End of Corporate News
09.08.2012 Dissemination of a Corporate News, transmitted by DGAP - acompany of EquityStory AG.The issuer is solely responsible for the content of this announcement.DGAP's Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Phone: +49 (0)9771 - 65-0 Fax: +49 (0)9771 - 97 467 E-mail: rka@rhoen-klinikum-ag.com Internet: www.rhoen-klinikum-ag.com ISIN: DE0007042301 WKN: 704230 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), München; Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service 
 181034 09.08.2012